Literature DB >> 18693761

Kempopeptins A and B, serine protease inhibitors with different selectivity profiles from a marine cyanobacterium, Lyngbya sp.

Kanchan Taori1, Valerie J Paul, Hendrik Luesch.   

Abstract

Two cyclodepsipeptides named kempopeptins A (1) and B (2) were isolated from a collection of a Floridian marine cyanobacterium, Lyngbya sp., that had previously afforded the structurally related potent elastase inhibitors lyngbyastatin 7 and somamide B. The structures of 1 and 2 were elucidated mainly by 1D and 2D NMR spectroscopy, and the absolute configuration was established by chiral HPLC and Marfey's analysis of the degradation products. Kempopeptin A (1) exhibited an IC50 against elastase of 0.32 microM and against chymotrypsin of 2.6 microM, while kempopeptin B (2) inhibited trypsin with an IC50 of 8.4 microM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18693761     DOI: 10.1021/np8002172

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  19 in total

1.  Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer.

Authors:  Fatma H Al-Awadhi; Valerie J Paul; Hendrik Luesch
Journal:  Chembiochem       Date:  2018-03-23       Impact factor: 3.164

Review 2.  Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery.

Authors:  George E Chlipala; Shunyan Mo; Jimmy Orjala
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

3.  Depsipeptides from a Guamanian Marine Cyanobacterium, Lyngbya bouillonii, with Selective Inhibition of Serine Proteases.

Authors:  Brent K Rubio; Stephen M Parrish; Wesley Yoshida; Peter J Schupp; Tom Schils; Philip G Williams
Journal:  Tetrahedron Lett       Date:  2010-12-22       Impact factor: 2.415

4.  Stigonemapeptin, an Ahp-containing depsipeptide with elastase inhibitory activity from the bloom-forming freshwater cyanobacterium Stigonema sp.

Authors:  Hahk-Soo Kang; Aleksej Krunic; Jimmy Orjala
Journal:  J Nat Prod       Date:  2012-04-06       Impact factor: 4.050

Review 5.  Therapeutic potential of marine peptides in cervical and ovarian cancers.

Authors:  Salman Ahmed; Haroon Khan; Sajad Fakhri; Michael Aschner; Wai San Cheang
Journal:  Mol Cell Biochem       Date:  2021-12-02       Impact factor: 3.396

Review 6.  New peptides isolated from Lyngbya species: a review.

Authors:  Li Liu; Kathleen S Rein
Journal:  Mar Drugs       Date:  2010-06-09       Impact factor: 5.118

Review 7.  Targeting eukaryotic proteases for natural products-based drug development.

Authors:  Fatma H Al-Awadhi; Hendrik Luesch
Journal:  Nat Prod Rep       Date:  2020-06-24       Impact factor: 13.423

8.  Lyngbyastatins 8-10, elastase inhibitors with cyclic depsipeptide scaffolds isolated from the marine cyanobacterium Lyngbya semiplena.

Authors:  Jason C Kwan; Kanchan Taori; Valerie J Paul; Hendrik Luesch
Journal:  Mar Drugs       Date:  2009-11-03       Impact factor: 5.118

Review 9.  Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis.

Authors:  Margarida Costa; João Costa-Rodrigues; Maria Helena Fernandes; Piedade Barros; Vitor Vasconcelos; Rosário Martins
Journal:  Mar Drugs       Date:  2012-09-28       Impact factor: 6.085

Review 10.  Pyridinoacridine alkaloids of marine origin: NMR and MS spectral data, synthesis, biosynthesis and biological activity.

Authors:  Louis P Sandjo; Victor Kuete; Maique W Biavatti
Journal:  Beilstein J Org Chem       Date:  2015-09-18       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.